Cargando…
ESCMID COVID-19 living guidelines: drug treatment and clinical management
SCOPE: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19. METHODS: An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small gro...
Autores principales: | Bartoletti, Michele, Azap, Ozlem, Barac, Aleksandra, Bussini, Linda, Ergonul, Onder, Krause, Robert, Paño-Pardo, José Ramón, Power, Nicholas R., Sibani, Marcella, Szabo, Balint Gergely, Tsiodras, Sotirios, Verweij, Paul E., Zollner-Schwetz, Ines, Rodríguez-Baño, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606314/ https://www.ncbi.nlm.nih.gov/pubmed/34823008 http://dx.doi.org/10.1016/j.cmi.2021.11.007 |
Ejemplares similares
-
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
por: Bartoletti, Michele, et al.
Publicado: (2022) -
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease
por: Bartoletti, Michele, et al.
Publicado: (2022) -
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
por: Barac, Aleksandra, et al.
Publicado: (2022) -
ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022) -
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)